Filing Details
- Accession Number:
- 0000950170-23-048195
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-14 16:30:13
- Reporting Period:
- 2023-09-13
- Accepted Time:
- 2023-09-14 16:30:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1840904 | Atai Life Sciences N.v. | ATAI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1860682 | Florian Brand | Wallstrabe 16 Berlin 2M 10179 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2023-09-13 | 40,000 | $1.45 | 110,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 2,333 | Indirect | By Spouse |
Footnotes
- The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.441 to $1.457. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.